Dramatic levodopa responsiveness of dystonia in a sporadic case of spinocerebellar ataxia type 3
R Nandagopal, SGK Moorthy - Postgraduate medical journal, 2004 - academic.oup.com
R Nandagopal, SGK Moorthy
Postgraduate medical journal, 2004•academic.oup.comA genetically confirmed case of spinocerebellar ataxia type 3 (SCA 3), presenting with
disabling foot dystonia, peripheral neuropathy, and minimal cerebellar signs is reported. The
dystonia improved dramatically with levodopa treatment in the absence of additional
parkinsonian feature. A trial of levodopa for dystonia in SCA 3 may be of therapeutic benefit,
at least in the initial stage of the disease.
disabling foot dystonia, peripheral neuropathy, and minimal cerebellar signs is reported. The
dystonia improved dramatically with levodopa treatment in the absence of additional
parkinsonian feature. A trial of levodopa for dystonia in SCA 3 may be of therapeutic benefit,
at least in the initial stage of the disease.
Abstract
A genetically confirmed case of spinocerebellar ataxia type 3 (SCA 3), presenting with disabling foot dystonia, peripheral neuropathy, and minimal cerebellar signs is reported. The dystonia improved dramatically with levodopa treatment in the absence of additional parkinsonian feature. A trial of levodopa for dystonia in SCA 3 may be of therapeutic benefit, at least in the initial stage of the disease.
Oxford University Press